Literature DB >> 26899954

Carriage of beta-lactamase-producing Enterobacteriaceae among nursing home residents in north Lebanon.

Iman Dandachi1, Elie Salem Sokhn1, Elie Najem1, Eid Azar1, Ziad Daoud2.   

Abstract

BACKGROUND: Multidrug-resistant (MDR) Enterobacteriaceae can cause severe infections with high morbidity, mortality, and health care costs. Individuals can be fecal carriers of these resistant organisms. Data on the extent of MDR Enterobacteriaceae fecal carriage in the community setting in Lebanon are very scarce. The aim of this study was to investigate the fecal carriage of MDR Enterobacteriaceae among the elderly residents of two nursing homes located in north Lebanon.
METHODS: Over a period of 4 months, five fecal swab samples were collected from each of 68 elderly persons at regular intervals of 3-4 weeks. Fecal swabs were subcultured on selective media for the screening of resistant organisms. The phenotypic detection of extended-spectrum beta-lactamase (ESBL), AmpC, metallo-beta-lactamase (MBL), and Klebsiella pneumoniae carbapenemase (KPC) production was performed using the beta-lactamase inhibitors ethylenediaminetetraacetic acid, phenylboronic acid, and cloxacillin. A temocillin disk was used for OXA-48. Multiplex PCRs were used for the genotypic detection of ESBL and carbapenemase genes, and sequencing was performed to identify CTX-M-15. The medical records of each subject were reviewed on a regular basis in order to assess the risk factors associated with MDR Enterobacteriaceae fecal carriage.
RESULTS: Over the study period, 76.5% of the recruited elderly persons were at least one-time carriers. A total of 178 isolates were obtained. Phenotypic testing revealed that 91.5% of them were ESBL producers, 4% were AmpC producers, 2.8% were co-producers of ESBL and AmpC, and 1.7% were co-producers of OXA-48 and ESBL. Recent antibiotic intake was found to be the only independent risk factor associated with the fecal carriage of MDR Enterobacteriaceae.
CONCLUSIONS: The high prevalence of MDR Enterobacteriaceae detected in this study and the emergence of carbapenem resistance is alarming. Efficient infection control measures and antibiotic stewardship programs are urgently needed in these settings in order to limit the spread of resistant strains.
Copyright © 2016 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Carbapenemases; Carriage; ESBLs; Nursing homes; Resistance

Mesh:

Substances:

Year:  2016        PMID: 26899954     DOI: 10.1016/j.ijid.2016.02.007

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  16 in total

1.  Molecular characterization of intestinal carriage of carbapenem-resistant Enterobacteriaceae among inpatients at two Iranian university hospitals: first report of co-production of bla NDM-7 and bla OXA-48.

Authors:  H Solgi; F Badmasti; Z Aminzadeh; C G Giske; M Pourahmad; F Vaziri; S A Havaei; F Shahcheraghi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-06-21       Impact factor: 3.267

Review 2.  OXA-48-like carbapenemases producing Enterobacteriaceae in different niches.

Authors:  Assia Mairi; Alix Pantel; Albert Sotto; Jean-Philippe Lavigne; Aziz Touati
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-10-08       Impact factor: 3.267

Review 3.  Carbapenem-Resistant Enterobacterales in Long-Term Care Facilities: A Global and Narrative Review.

Authors:  Hsin-Yu Chen; Shio-Shin Jean; Yu-Lin Lee; Min-Chi Lu; Wen-Chien Ko; Po-Yu Liu; Po-Ren Hsueh
Journal:  Front Cell Infect Microbiol       Date:  2021-04-23       Impact factor: 5.293

4.  Prevalence and characterisation of carbapenemase encoding genes in multidrug-resistant Gram-negative bacilli.

Authors:  Sayran Hamad Haji; Safaa Toma Hanna Aka; Fattma A Ali
Journal:  PLoS One       Date:  2021-11-01       Impact factor: 3.240

5.  An antibiotic stewardship exercise in the ICU: building a treatment algorithm for the management of ventilator-associated pneumonia based on local epidemiology and the 2016 Infectious Diseases Society of America/American Thoracic Society guidelines.

Authors:  Lyn S Awad; Dania I Abdallah; Anas M Mugharbil; Tamima H Jisr; Nabila S Droubi; Nabila A El-Rajab; Rima A Moghnieh
Journal:  Infect Drug Resist       Date:  2017-12-22       Impact factor: 4.003

6.  Prevalence and Characterization of Multi-Drug-Resistant Gram-Negative Bacilli Isolated From Lebanese Poultry: A Nationwide Study.

Authors:  Iman Dandachi; Elie S Sokhn; Elias A Dahdouh; Eid Azar; Bassel El-Bazzal; Jean-Marc Rolain; Ziad Daoud
Journal:  Front Microbiol       Date:  2018-03-23       Impact factor: 5.640

7.  Extended-spectrum β-lactamase, plasmid-mediated AmpC β-lactamase, fluoroquinolone resistance, and decreased susceptibility to carbapenems in Enterobacteriaceae: fecal carriage rates and associated risk factors in the community of Northern Cyprus.

Authors:  Emrah Ruh; Jonathan Zakka; Kujtesa Hoti; Arezou Fekrat; Emrah Guler; Umut Gazi; Zafer Erdogmus; Kaya Suer
Journal:  Antimicrob Resist Infect Control       Date:  2019-06-10       Impact factor: 4.887

8.  Epidemiology, risk factors, and prediction score of carbapenem resistance among inpatients colonized or infected with 3rd generation cephalosporin resistant Enterobacterales.

Authors:  Rima Moghnieh; Dania Abdallah; Marwa Jadayel; Wael Zorkot; Hassan El Masri; Marie Joe Dib; Tasnim Omar; Loubna Sinno; Rawad Lakkis; Tamima Jisr
Journal:  Sci Rep       Date:  2021-07-20       Impact factor: 4.379

9.  Molecular Epidemiology of OXA-48 and NDM-1 Producing Enterobacterales Species at a University Hospital in Tehran, Iran, Between 2015 and 2016.

Authors:  Hamid Solgi; Shoeib Nematzadeh; Christian G Giske; Farzad Badmasti; Fredrik Westerlund; Yii-Lih Lin; Gaurav Goyal; Vajihe Sadat Nikbin; Amir Hesam Nemati; Fereshteh Shahcheraghi
Journal:  Front Microbiol       Date:  2020-05-28       Impact factor: 5.640

Review 10.  Understanding the Epidemiology of Multi-Drug Resistant Gram-Negative Bacilli in the Middle East Using a One Health Approach.

Authors:  Iman Dandachi; Amer Chaddad; Jason Hanna; Jessika Matta; Ziad Daoud
Journal:  Front Microbiol       Date:  2019-08-23       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.